Related Articles
Downregulation of high mobility group protein box‑1 resensitizes ovarian cancer cells to carboplatin
Treatment effects of oxaliplatin combined with gemcitabine on colorectal cancer and its influence on HMGB1 expression
BRCA1 promoter hypermethylation in sporadic epithelial ovarian carcinoma: Association with low expression of BRCA1, improved survival and co‑expression of DNA methyltransferases
Expression levels of MRP1, GST-π, and GSK3β in ovarian cancer and the relationship with drug resistance and prognosis of patients
Expression levels and clinical significance of hepsin and HMGB1 proteins in cervical carcinoma